NEW YORK (GenomeWeb) – Device firm EKF Diagnostics said that it is considering plans to split into two separate companies — one focused on point-of-care testing and the other on laboratory diagnostics.

As part of this plan, the company said it would delist its shares from the AIM market and seek listings for each new company separately in a market to be determined.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.